Kodak no longer seems a short play for the long term. If they have retooled for manufacturing the ingredients for generic drugs, then they should do very very well. We get most of those precursors from China, and we all want away from China. Hence their $750 mill loan from the gubmint. Makes sense for them too, as they used to manufacture chemicals. They're not reinventing their own wheel, just making a different flavor of that wheel.
I do not follow companies and their balance sheets, know their management teams, how they manage their cash and expenses and all those things that make a stock a good investment. In principle, manufacturing the chemicals needed to make generic drugs domestically seems a wise move, and a wise stock choice FOR THE LONG TERM INVESTOR. How the current volatility plays out for short-term trading Kodak to make some bucks I could not tell you. Seek @vanzandt He's got pencils that fly and make pretty colors.